In The Spotlight
DDNews Cancer Research Exclusive
(Photo credit: Stephan Lab / Fred Hutchinson Cancer Research Center)
Biomedical mesh loaded with T cells and implanted on tumors led to tumor clearance in mouse models, Fred Hutchinson team reports
AbbVie and I-Mab to develop and commercialize I-Mabís anti-CD47 monoclonal antibody lemzoparlimab
Are cancer stem cells a better oncology target?
Immunomedics shares strong data for Trodelvy in triple-negative breast cancer
U.K.-Italy collaboration aims for precision oncology at scale
Kiadis, Sanofi ink license agreement for natural killer therapeutics
ISA Pharmaceuticals strengthens strategic immuno-oncology collaboration with Regeneron
A new collaboration is underway between Sermonix Pharmaceuticals Inc. and Eli Lilly and Co.
Clinical-stage oncology company AnHeart Therapeutics Co. Ltd. has outlicensed clinical development and commercialization rights to taletrectinib to NewG Lab Co. Ltd. via AnHeart Therapeutics Inc., its subsidiary
Recent happenings on the R&D front to better understand cancer and create oncology therapeutics
by Martin Lachs/Brandon Fletcher
As excitement and investment related to adoptive cell transfer products increases, there are concerns and issues that need to be addressed in terms of long-term follow-up trials

by Sue Cramp, Charles River
In pursuit of new options for treating childhood cancers, a new approach to drug discovery and development may be an answer

by Andrea Toell of Lonza
Andrea Toell of Lonza shares how CAR T cells are transforming immuno-oncology

1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.